Recent studies demonstrate that in pulmonary fibrosis, ET-1, CTGF, and the balance between MMPs and their tissue inhibitors TIMPs interact in a complex crosstalk that drives the progression of the disease13. This evidence concerns the gene CCN2 and pulmonary fibrosis.